So far, China has made no official public threat about weaponizing its dominant position in this segment of the pharmaceutical industry. But Trump’s tariffs on the sector, if imposed, could worsen ...

AstraZeneca AZN1.05%increase; green up pointing triangle plans to invest $2.5 billion in China over five years to build a research-and-development center and strike deals with local biotechnology ...

An colon cancer study highlighted the importance of the National Cancer Institute, while cancer doctors got a look at a ...

A summary of current health news includes topics such as the Trump administration's inaccurate health report, China's ban on ...

Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), AstraZeneca PLC (AZN) and ...

Kicking off this week in Chicago, this year’s American Association for Cancer Research conference will feature presentations ...

Vodafone Idea, Nykaa, Apollo Hospitals, AstraZeneca Pharma, IndiGo, Adani Energy Solutions, M&M and Puravankara are among the ...

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

Asandeutertinib is a derivative of Tagrisso designed to avoid certain toxic side effects in patients with EGFR-mutated NSCLC.